SEC adopts shorter reporting deadlines for beneficial ownership
By 
Kyle Brasseur2023-10-10T19:33:00
The Securities and Exchange Commission (SEC) finalized its rule proposal to cut in half the timeline allowed for market participants to file initial beneficial ownership information with the agency.
The rule, adopted Tuesday, shortens the deadline for those who own more than 5 percent of a company to inform the public of their position from 10 days to five days.
“In our fast-paced markets, it shouldn’t take 10 days for the public to learn about an attempt to change or influence control of a public company,” said SEC Chair Gary Gensler in a press release.
Related articles
-
News BriefHG Vora fined $950K for beneficial ownership disclosure failures
New York-based investment adviser HG Vora Capital Management agreed to pay $950,000 to settle charges levied by the Securities and Exchange Commission alleging failure to report beneficial ownership regarding its stake at trucking transport company Ryder System.
-
News BriefCybersecurity, AML risks among SEC 2024 exam priorities
SEC examiners will be asking tough questions of registered firms regarding how they handle risks related to operational security, interact with financial technology companies and crypto assets, and the maturity of their anti-money laundering programs.
-
News BriefFinCEN proposes beneficial ownership reporting extension for 2024 companies
The Financial Crimes Enforcement Network announced a notice of proposed rulemaking to extend the deadline for companies created or registered in 2024 to file their initial beneficial ownership information reports.
More from Regulatory Policy
-
News BriefSEC exam priorities for 2026 signal heightened focus on firmwide compliance
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
-
ArticlePharma sector boom puts pressure on compliance to counter financial crime
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
-
News BriefCostco sues federal government over Trump-era tariffs, seeks refund rights
Wholesale retailer Costco would like a tariff refund from the U.S. government, if the U.S. Supreme Court rules that President Donald Trump overstepped his authority by imposing them.